First evident generation of purin-2-yllithium: Lithiation of an 8-silyl- protected 6-chloropurine riboside as a key step for the synthesis of 2- carbon-substituted adenosines

Journal of Organic Chemistry

Volumn 64, Issue 21, 1999, Pages 7773-7780

  Kumamoto, Hiroki ^c   Tanaka, Hiromichi ^c   Tsukioka, Ryota ^c   Ishida, Yumiko ^c   Nakamura, Akiko ^c   Kimura, Satoe ^c   Hayakawa, Hiroyuki ^a,c   Kato, Keisuke ^b,c   Miyasaka, Tadashi ^c  

^a Tsumura Ctrl Research Laboratories   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 PURINYLLITHIUM DERIVATIVE; 6 CHLORO 9 (2,3 O ISOPROPYLIDENE 5 O TRITYL BETA DEXTRO RIBOFURANOSYL) 8 (TRIISOPROPYLSILYL)PURINE; ADENOSINE DERIVATIVE; LITHIUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BINDING; CHEMICAL REACTION KINETICS; CHEMICAL STRUCTURE; ORGANIC CHEMISTRY; REACTION ANALYSIS; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0032717557     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9906577     Document Type: Article

References (33)

1. For a review article, see: Srivastava, P. C.; Robins, R. K.; Meyer, R. B., Jr. In Chemistry of Nucleosides and Nucleotides; Townsend, L. B., Ed.; Plenum Press: New York, 1988; Vol. 1, pp 1-281.
2. Tanaka, H.; Hayakawa, H.; Miyasaka, T. Tetrahedron 1982, 38, 2635-2642.
3. Barton, D. H. R.; Hedgecock, C. J. R.; Lederer, E.; Motherwell, W. B. Tetrahedron Lett. 1979, 279-280.
4. Tanaka, H.; Uchida, Y.; Shinozaki, M.; Hayakawa, H.; Matsuda, A.; Miyasaka, T. Chem. Pharm. Bull. 1983, 31, 787-790.
5. Hayakawa, H.; Haraguchi, K.; Tanaka, H.; Miyasaka, T. Chem. Pharm. Bull. 1987, 35, 72-79.
6. (a) Kato, K.; Hayakawa, H.; Tanaka, H.; Kumamoto, H.; Miyasaka, T. Tetrahedron Lett. 1995, 36, 6507-6510.
7. (b) Kato, K.; Hayakawa, H.; Tanaka, H.; Kumamoto, H.; Shindoh, S.; Shuto, S.; Miyasaka, T. J. Org. Chem. 1997, 62, 6833-6841.
8. The 2-lithio derivative of an 8-azapurine, 3H-1,2,3-triazolo-[4,5-d]pyrimidine, has been generated through a halogen-lithium exchange reaction: Tanji, K.; Kato, H.; Higashino, T. Chem. Pharm. Bull. 1991, 39, 3037-3040.
9. This deshielding effect is ascribed to the preferred syn-glycosidic conformation of 8-substituted purine nucleosides: Sarma, R. H.; Lee, C.-H.; Evans, F. E.; Yathindra, N.; Sundaralingam, M. J. Am. Chem. Soc. 1974, 96, 7337-7348.
10. 1 epoxide with calf thymus DNA: Iyer, E. S.; Voehler, M. W.; Harris, T. M. J. Am. Chem. Soc. 1994, 116, 8863-8869.
11. For reports concerning anionic migration of TBDMS and TIPS groups from oxygen to carbon, see: (a) Bures, E. J.; Keay, B. A. Tetrahedron Lett. 1987, 28, 5965-5968.
12. (b) Lautens, M.; Delanghe, P. H. M.; Goh, J. B.; Zhang, C. H. J. Org. Chem. 1992, 57, 3270-3272.
13. (c) He, H.-M.; Fanwick, P. E.; Wood, K.; Cushman, M. J. Org. Chem. 1995, 60, 5905-5909.
14. For a review concerning the Stille reaction, see: Mitchell, T. N. Synthesis 1992, 803-815.
15. Saenger, W. Principles of Nucleic Acid Structure; Springer-Verlag: New York, 1984.
16. Fox, I. H.; Kelley, W. N. Annu. Rev. Biochem. 1978, 47, 655-686.
17. Davoll, J.; Lowy, B. A. J. Am. Chem. Soc. 1952, 74, 1563-1566.
18. This method has been applied to the synthesis of 2-(trifluoro-methyl)adenosine: Gough, G.; Maguire, M. H. J. Med. Chem. 1965, 8, 866-867.
19. For a review article, see: Yamazaki, A.; Okutsu, M. J. Heterocycl. Chem. 1978, 15, 353-358.
20. Yamazaki, A.; Kumasiro, I.; Takenishi, T. J. Org. Chem. 1968, 33, 2583-2586.
21. Marumoto, R.; Yoshioka, Y.; Miyashita, O.; Shima, S.; Imai, K.; Kawazoe, K.; Honjo, M. Chem. Pharm. Bull. 1975, 23, 759-774.
22. Murakami, T.; Otsuka, M.; Kobayashi, S.; Ohno, M. Heterocycles 1981, 16, 1315-1319.
23. For the synthesis of 2-carbon-substituted analogues of other purine nucleosides by this method: (a) Yamazaki, A.; Kumashiro, I.; Takenishi, T. J. Org. Chem. 1967, 32, 3258-3260.
24. (b) Zhang, H.-Z.; Fried, J. Synth. Commun. 1996, 26, 351-355.
25. Zhang, H.-Z.; Rao, K.; Carr, S. F.; Papp, E.; Straub, K.; Wu, J. C.; Fried, J. J. Med. Chem. 1997, 40, 4-8.
26. Maeda, M.; Nushi, K.; Kawazoe, Y. Tetrahedron 1974, 30, 2677-2682.
27. Matsuda, A.; Nomoto, Y.; Ueda, T. Chem. Pharm. Bull. 1979, 27, 183-192.
28. (a) Nair, V.; Purdy, D. F.; Sells, T. B. J. Chem. Soc., Chem. Commun. 1989, 878-879.
29. (b) Nair, V.; Purdy, D. F. Tetrahedron 1991, 47, 365-382.
30. Matsuda, A.; Shinozaki, M.; Yamaguchi, T.; Homma, H.; Nomoto, R.; Miyasaka, T.; Watanabe, Y.; Abiru, T. J. Med. Chem. 1992, 35, 241-252.
31. Camaioni, E.; Di Francesco, E.; Vittori, S.; Volpini, R.; Cristalli, G. Bioorg. Med. Chem. 1997, 5, 2267-2275.
32. Kumamoto, H.; Hayakawa, H.; Tanaka, H.; Shindoh, S.; Kato, K.; Miyasaka, T.; Endo, K.; Machida, H.; Matsuda, A. Nucleosides Nucleotides 1998, 17, 15-27.
33. In the lithiation of tert-benzamides, the TMS group has been used to mask the more reactive site ortho to a carboxamide: Mills, R. J.; Snieckus, V. J. Org. Chem. 1983, 48, 1565-1568.